Unambiguous identification and quantification of CRC cells at these early time points required the injection of higher cell numbers (5 × 105 CT26 cells/mouse) and the adaptation of molecular and immunohistochemical analyses detecting a CT26 cell‐specific marker (achieved by stably expressing the RFP reporter gene into CT26 cells). Here, DDX53 is linked to colorectal carcinoma.